Recipharm AB:企業のM&A・事業提携・投資動向

◆英語タイトル:Recipharm AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2027
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:144
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Recipharm AB – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Recipharm AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Recipharm AB since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Recipharm AB’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Recipharm AB. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Recipharm AB’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Recipharm AB and its subsidiaries since 2007.
- Information about key financial and legal advisors for Recipharm AB’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Recipharm AB’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
PARTNERSHIP 104
Partnership – Overview 104
Partnership – Deal reports 105
CAPITAL RAISING 119
Capital Raising – Overview 119
Capital Raising – Deal reports 120
DIVESTMENTS 124
Divestments – Overview 124
Divestments – Deal reports 125
PRIVATE EQUITY & OWNERSHIP 133
Private Equity and Ownership – Deal reports 133
APPENDIX 134
Contact Us 134
About MarketLine Financial Deals Database 134
Deal Definition and Methodology 136
About MarketLine 143

List of Tables
Table 1: Recipharm AB M&A volume and value trend (2014-YTD2018)
Table 2: Recipharm AB M&A activity by geography (2014-YTD2018)
Table 3: Recipharm AB partnership volume and value trend (2014-YTD2018)
Table 4: Recipharm AB partnership trend by key deal type (2014-YTD2018)
Table 5: Recipharm AB capital raising volume and value trend (2014-YTD2018)
Table 6: Recipharm AB capital raising by deal type (2014-YTD2018)
Table 7: Recipharm AB divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Recipharm AB M&A volume and value trend (2014-YTD2018)
Figure 2: Recipharm AB M&A activity by geography (2014-YTD2018)
Figure 3: Recipharm AB partnership volume and value trend (2014-YTD2018)
Figure 4: Recipharm AB partnership trend by key deal type (2014-YTD2018)
Figure 5: Recipharm AB capital raising volume and value trend (2014-YTD2018)
Figure 6: Recipharm AB capital raising by deal type (2014-YTD2018)
Figure 7: Recipharm AB divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Recipharm AB:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hoverink Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Hoverink Biotechnologies Inc (Hoverink) formerly Hoverink International Holdings Inc, is a preclinical biopharmaceutical company that discovers, develops, manufactures, and commercializes pharmaceutical preparations and drug treatment for age-related diseases, cancer, gastrointestinal and on …
  • Actuate Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actuate Therapeutics Inc (Actuate Therapeutics) is a biopharmaceutical company that offers development of novel compounds for the treatment of cancer and inflammatory diseases. The company’s lead compound 9-ING-41 is under evaluation for anti-tumor activity in various vivo models. It also de …
  • Amec Foster Wheeler plc (formerly AMEC plc):戦略・SWOT・企業財務分析
    Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report Summary Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Radiomedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that provides therapies. The company provides radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. Its products include smartmedix system and glucomedix. Radiomedix’s services include CGMP drug manufacturing suite and mi …
  • Vectura Group plc:企業の戦略・SWOT・財務情報
    Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Allscripts Healthcare Solutions Inc (MDRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Allscripts Healthcare Solutions Inc (Allscripts), formerly Allscripts-Misys Healthcare Solutions, Inc., is a provider of healthcare information technology solutions. The company’s major solutions include Electronic Health Records (EHR), Financial Management Solutions, Population Health Manag …
  • Rhenovia Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Rhenovia Pharma Ltd (Rhenovia) is a biotechnology company that provides solutions for the treatment of Alzheimers disease and other central nervous system diseases. The company offers studies to academic research groups and industries based on biosimulation technology, which is a computation …
  • Les Laboratoires Servier SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Les Laboratoires Servier SAS (Servier) researches, develops, manufactures and markets drugs for treating various diseases. The company's portfolio of marketed products treat central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, women's …
  • Rosenergoatom Concern:企業の戦略的SWOT分析
    Rosenergoatom Concern - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Electricity Generating Authority of Thailand:発電所・企業SWOT分析
    Electricity Generating Authority of Thailand - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Banco Santander (Brasil) SA:企業のM&A・事業提携・投資動向
    Banco Santander (Brasil) SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Santander (Brasil) SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Charter Hall Group:企業のM&A・事業提携・投資動向
    Charter Hall Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Charter Hall Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Nakheel
    Nakheel - Strategy, SWOT and Corporate Finance Report Summary Nakheel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • SK Innovation Co., Ltd.:企業の戦略・SWOT・財務情報
    SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Iridex Corp (IRIX):企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • Fintel Energia Group SpA (FTL):企業の財務・戦略的SWOT分析
    Summary Fintel Energia Group SpA (Fintel) is a utility service provider that supplies electricity and natural gas. The company's services include designing, consultation, and installation of technologies and system of production of renewable energies for the Group and to third parties. It also provi …
  • Telefonaktiebolaget LM Ericsson (ERIC B):企業の財務・戦略的SWOT分析
    Telefonaktiebolaget LM Ericsson (ERIC B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報
    Summary Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specime …
  • bioLytical Laboratories Inc:製品パイプライン分析
    Summary bioLytical Laboratories Inc (bioLytical) is a medical device company that develops and manufactures HIV diagnostic products. The company offers products such as insti HIV-1/HIV-2 antibody test and insti HIV-1/HIV-2 test controls. Its product line provides test results that translates into a …
  • Intrexon Corp (XON):企業の財務・戦略的SWOT分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a synthetic biology service provider. The company operates through its divisions and units such as cell engineering, data sciences and computational biology, information technology (IT), actobiotics, molecular engineering, agricultural bio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆